Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Change In Receivables?

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-30 Mil. It means Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Accounts Receivable increased by ¥30 Mil from Dec. 2022 to Dec. 2023 .

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥458 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 33.77.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥-91 Mil.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Change In Receivables Chart

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-18.26

-49.33

-73.83

-18.43

-30.27

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	457.924	/	1237.408	*	91
=	33.77

2. In Ben Graham's calculation of liquidation value, Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	382.473	-	1075.166	+	0.75 * 457.924	+	0.5 * 516.842
=	-91

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 18, Youlian 1st Street, 13th Floor, Jinniu District, Sichuan Province, Chengdu, CHN, 610081

Website

https://www.hezongyy.com

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd provides convenient, efficient and low-cost medical circulation services for the vast community medical terminals and primary medical institutions. It offers various products such as respiratory system, cardiovascular and neurological drugs, biological product, rheumatism and bone injuries and other medicines, cardiovascular and neurological drugs and others.

Executives

Tian Wen Shu	Supervisors
Ai Ying Ping	Director
Lei Qi Gang	Executives
Hao Rui Zhi	Directors, Directors, and Executives

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Headlines

No Headlines